Biosynex
Biosynex SA designs, manufactures, and distributes rapid diagnostic tests to patients and healthcare professionals in France and internationally. The company develops and markets IVDs in the form of RDTs and TRODs, immunoblot, molecular biology, and POC for screening, diagnosis, and prevention. It also provides thermometers, tensiometers, oximetry, hearing protection products, oral and dental hyg… Read more
Biosynex (ALBIO) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.160x
Based on the latest financial reports, Biosynex (ALBIO) has a cash flow conversion efficiency ratio of -0.160x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-7.07 Million) by net assets (€44.31 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Biosynex - Cash Flow Conversion Efficiency Trend (2008–2024)
This chart illustrates how Biosynex's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Biosynex Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Biosynex ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Doubledown Interactive Co Ltd
NASDAQ:DDI
|
0.044x |
|
486630
KQ:486630
|
N/A |
|
Sintex Plastics Technology Limited
NSE:SPTL
|
-11.870x |
|
GROUP PAREF INH. EO 25
F:G5I
|
N/A |
|
Khadim India Limited
NSE:KHADIM
|
0.004x |
|
Bio Green Energy Tech PCL
BK:BIOTEC
|
-0.029x |
|
KENTANIX SUPRA INTERNATIONAL TBK
JK:KSIX
|
N/A |
|
EKOPAK N.V.
F:7XZ
|
N/A |
Annual Cash Flow Conversion Efficiency for Biosynex (2008–2024)
The table below shows the annual cash flow conversion efficiency of Biosynex from 2008 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €80.50 Million | €-10.12 Million | -0.126x | -61.91% |
| 2023-12-31 | €124.31 Million | €-9.65 Million | -0.078x | -361.86% |
| 2022-12-31 | €166.76 Million | €4.95 Million | 0.030x | -95.47% |
| 2021-12-31 | €167.81 Million | €109.83 Million | 0.655x | +37.14% |
| 2020-12-31 | €66.29 Million | €31.64 Million | 0.477x | +1213.25% |
| 2019-12-31 | €30.38 Million | €1.10 Million | 0.036x | +127.67% |
| 2018-12-31 | €29.26 Million | €467.12K | 0.016x | -4.82% |
| 2017-12-31 | €28.91 Million | €484.82K | 0.017x | -16.59% |
| 2016-12-31 | €24.36 Million | €489.91K | 0.020x | -7.96% |
| 2015-12-31 | €21.13 Million | €461.66K | 0.022x | +110.31% |
| 2009-12-31 | €-341.55K | €72.40K | -0.212x | -117.67% |
| 2008-12-31 | €-153.74K | €-184.44K | 1.200x | -- |